← Back to Search

Behavioural Intervention

Connections App for Alcoholic Liver Disease (IMPACT-ALD Trial)

N/A

Waitlist Available

Led By Andrew Quanbeck, PhD

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 months, 6 months

Awards & highlights

IMPACT-ALD Trial Summary

This trial will test a smartphone app called CHESS Health Connections among patients with alcohol-associated liver disease in Michigan and Wisconsin. The goal is to help patients stop drinking alcohol earlier in their disease and improve their

Who is the study for?

This trial is for individuals with alcohol-associated liver disease (ALD) who are being treated at two medical centers in Michigan and Wisconsin. It's open to patients from general hepatology clinics as well as those receiving integrated care for advanced ALD, mental health, and substance abuse.Check my eligibility

What is being tested?

The study is testing the CHESS Health Connections smartphone app's effectiveness in helping ALD patients quit drinking. Participants will be randomly assigned to use the app or not, and their progress will be tracked over a six-month period.See study design

What are the potential side effects?

Since this trial involves a mobile-based program rather than medication, traditional side effects are not expected. However, participants may experience stress or frustration if they find using the app challenging.

IMPACT-ALD Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 months, 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 months, 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Days of Alcohol Abstinence in ALD Participants

Number of Standard Drinks Consumed in ALD Participants

Secondary outcome measures

Change in CHESS Bonding Scale Score

Change in Drinking Motivations Questionnaire - Adult (DMQ-A) Score

Change in Drug-Taking Confidence Questionnaire (DTCQ-8A) Score

+6 more

IMPACT-ALD Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Connections AppExperimental Treatment1 Intervention

The Connections app is based on principles of effective care for substance use disorders, such as sustained duration, peer support, improving coping skills in high-risk situations, assertive outreach, self- monitoring, prompts, and action planning. The theoretical foundation of CHESS Health is self-determination theory, which holds that an individual's adaptive functioning can be improved if the patient feels (1) competent, (2) related to others, and (3) internally motivated rather than coerced in one's actions.

Group II: Treatment as UsualActive Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH

805 Previous Clinical Trials

1,365,614 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,619,341 Total Patients Enrolled

University of Wisconsin, MadisonLead Sponsor

1,190 Previous Clinical Trials

3,169,329 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are prospective participants able to enroll in this research study at the present time?

"According to clinicaltrials.gov, the current status of this study is not recruiting new participants. The trial was initially listed on May 1st, 2024 and its latest update occurred on March 5th, 2024. While this particular trial is no longer accepting applicants, there are a total of 540 other trials actively seeking participants at present."

Answered by AI

What is the primary goal behind conducting this medical trial?

"The primary objective of this trial, monitored on a monthly basis for up to 6 months, is assessing the Quantity of Standard Drinks Consumed by individuals with ALD. Secondary measures encompass alterations in Pain Interference as assessed by PEG Score ranging from 0 (no pain or interference) to 10 (severe discomfort and complete hindrance), variations in Drinking Motivations Questionnaire - Adult (DMQ-A) Score reflecting motivations across social, coping, confidence, taste, and enhancement domains each scored between 1-5 where elevated scores indicate heightened motivation to consume alcohol; additionally evaluating changes in CHESS Bonding Scale Scores that"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease

2024. "Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06305624.

All > Liver Disease